This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Raitt, M. H. Articles by Hallstrom, A. P. Search for Related Content PubMed PubMed Citation Articles by Raitt, M. H. Articles by Hallstrom, A. P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB AMIODARONE HYDROCHLORIDE Medline Plus Health Information Pacemakers and Implantable Defibrillators Related Collections Ablation/ICD/surgery Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2001;103:244.)
© 2001 American Heart Association, Inc.

Clinical Investigation and Reports

"Stable" Ventricular Tachycardia Is Not a Benign Rhythm

Insights From the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry

Merritt H. Raitt, MD; Ellen Graham Renfroe, RN; Andrew E. Epstein, MD; John H. McAnulty, MD; Paul Mounsey, MD; Jonathan S. Steinberg, MD; Scott E. Lancaster, MS; Ram L. Jadonath, MD; Alfred P. Hallstrom, PhD; for the AVID Investigators

From the Portland VA Medical Center, Portland, Ore (M.H.R.); University of Washington, Seattle (E.G.R., S.E.L., A.P.H.); University of Alabama, Birmingham (A.E.E.); Oregon Health Sciences University, Portland (J.H.M.); University of Virginia Medical Center, Charlottesville (P.M.); St. Luke’s-Roosevelt Hospital Center, New York, NY (J.S.S.); and North Shore University Hospital, Manhasset, NY (R.L.J.).

Correspondence to AVID Clinical Trial Center, 1107 NE 45th St, Room 505, Seattle, WA 98105. E-mail avidctc{at}u.washington.edu

Background—Sustained ventricular tachycardia (VT) can be unstable, can be associated with serious symptoms, or can be stable and relatively free of symptoms. Patients with unstable VT are at high risk for sudden death and are best treated with an implantable defibrillator. The prognosis of patients with stable VT is controversial, and it is unknown whether implantable cardioverter-defibrillator therapy is beneficial.

Methods and Results—Screening for the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial identified patients with both stable and unstable VT. Both groups were included in a registry, and their clinical characteristics and discharge treatments were recorded. Mortality data were obtained through the National Death Index. The mortality in 440 patients with stable VT tended to be greater than that observed in 1029 patients presenting with unstable VT (33.6% versus 27.6% at 3 years; relative risk [RR]=1.22; P=0.07). After adjustment for baseline and treatment differences, the RR was little changed (RR=1.25, P=0.06).

Conclusions—Sustained VT without serious symptoms or hemodynamic compromise is associated with a high mortality rate and may be a marker for a substrate capable of producing a more malignant arrhythmia. Implantable cardioverter-defibrillator therapy may be indicated in patients presenting with stable VT.

Key Words: death, sudden • tachycardia • cardioversion • defibrillation

This article has been cited by other articles:

				P. Vassallo and R. G. Trohman Prescribing Amiodarone: An Evidence-Based Review of Clinical Indications JAMA, September 19, 2007; 298(11): 1312 - 1322. [Abstract] [Full Text] [PDF]

				D. J. Callans Patients With Hemodynamically Tolerated Ventricular Tachycardia Require Implantable Cardioverter-Defibrillators Circulation, September 4, 2007; 116(10): 1196 - 1203. [Full Text] [PDF]

				J. Almendral and M. E. Josephson All Patients With Hemodynamically Tolerated Postinfarction Ventricular Tachycardia Do Not Require an Implantable Cardioverter-Defibrillator Circulation, September 4, 2007; 116(10): 1204 - 1212. [Full Text] [PDF]

				T. J. Bunch, S. C. Hammill, and R. D. White Outcomes After Ventricular Fibrillation Out-of-Hospital Cardiac Arrest: Expanding the Chain of Survival Mayo Clin. Proc., June 1, 2005; 80(6): 774 - 782. [Abstract] [PDF]

				J.u. Schlapfer, F. Rapp, L. Kappenberger, and M. Fromer Electrophysiologically guided amiodarone therapy versus the implantable cardioverter-defibrillator for sustained ventricular tachyarrhythmias after myocardial infarction: Results of long-term follow-up J. Am. Coll. Cardiol., June 5, 2002; 39(11): 1813 - 1819. [Abstract] [Full Text] [PDF]

				P. Della Bella, R. De Ponti, J.A.S. Uriarte, C. Tondo, C. Klersy, C. Carbucicchio, C. Storti, S. Riva, and M. Longobardi Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia. Long-term outcome in relation to acute electrophysiological findings Eur. Heart J., March 1, 2002; 23(5): 414 - 424. [Abstract] [Full Text] [PDF]

				S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450. [PDF]

				'Stable' Ventricular Tachycardia Is Not Benign Journal Watch Cardiology, April 6, 2001; 2001(406): 2 - 2. [Full Text]